<!-- mobian-agent-page publisher="time" canonical="https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/" -->

---
title: Ecstasy: FDA Approves Trial of MDMA as PTSD Treatment
description: The Food and Drug Administration has approved the use of ecstasy in large-scale trials as a treatment for post-traumatic stress disorder
canonical: https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/
author: Suyin Haynes
article:opinion: false
article:content_tier: free
article:published_time: 2016-11-30T15:50:21.000Z
article:modified_time: 2026-02-23T02:03:17.836Z
article:section: Health
og:title: FDA Approves Large-Scale Trial of Ecstasy as PTSD Treatment
og:description: The Phase 3 trial is last step on the way to approval as a prescription drug
og:url: https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/
og:site_name: TIME
og:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltde093bcdab65f2d0/6988d9b9bc6cfc69913e2a3c/time-logo.jpg?branch=production
og:image:width: 1200
og:image:height: 675
og:image:alt: TIME
og:type: article
twitter:card: summary_large_image
twitter:title: FDA Approves Large-Scale Trial of Ecstasy as PTSD Treatment
twitter:description: The Phase 3 trial is last step on the way to approval as a prescription drug
twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltde093bcdab65f2d0/6988d9b9bc6cfc69913e2a3c/time-logo.jpg?branch=production
---

# A Large Study of Ecstasy for PTSD Gets the Green Light


by 

[Suyin Haynes](https://time.com/author/suyin-haynes/)


## Suyin Haynes


Nov 30, 2016 3:50 PM UTC

by 

[Suyin Haynes](https://time.com/author/suyin-haynes/)


## Suyin Haynes


Nov 30, 2016 3:50 PM UTC

The Food and Drug Administration (FDA) has approved the use of MDMA in large-scale trials as a treatment for post-traumatic stress disorder (PTSD).

[Small scale studies](http://content.time.com/time/health/article/0,8599,2004887,00.html?iid=sr-link1) have previously used the drug, also known as the party-drug ecstasy, to alleviate some of the symptoms of PTSD. As reported by the [_New York_ _Times_,](http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html?%5Fr=0) the FDA green lit a Phase 3 clinical trial, which is significant as it marks the final stage of testing before it can be submitted for approval as a prescription drug.

Dr. Charles R. Marmar, the head of psychiatry at New York University’s Langone School of Medicine and a leading PTSD researcher, told the _Times_ that he was “cautious but hopeful.”

[Study participants](http://jop.sagepub.com/content/early/2012/08/29/0269881112456611.abstract) have previously reported significant improvements in their condition following a course of MDMA therapy, and researchers have been optimistic about the future of the drug as a form of treatment. “If they can keep getting good results, it will be of great use,” Marmar said. However, he also voiced some caution, which was echoed by other reactions to the FDA’s approval. “It’s a feel-good drug, and we know people are prone to abuse it,” he said.

Through a spokeswoman, the FDA declined to comment to the _Times_, citing regulations that prohibit disclosing information about drugs that are being developed.

\[[_NYT_](http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html?%5Fr=0)\]

```json
[{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/"},"headline":"A Large Study of Ecstasy for PTSD Gets the Green Light","datePublished":"2016-11-30T15:50:21.000Z","dateModified":"2026-02-23T02:03:17.836Z","description":"The Phase 3 trial is last step on the way to approval as a prescription drug","url":"https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/","keywords":["Drugs","Food and Drug Administration","ecstasy"],"thumbnailUrl":"","author":[{"@type":"Person","name":"Suyin Haynes","jobTitle":null,"url":"https://time.com/author/suyin-haynes/"}],"articleSection":"Health","image":[],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/drugs/","name":"Drugs"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/4586014/fda-ecstasy-mdma-ptsd-treatment-trial/","name":"A Large Study of Ecstasy for PTSD Gets the Green Light"}}]}]
```

